Sort
82,697 grants matching “vaccine development”
Phase 2 trial of a novel peptide vaccine targeting CMV antigen for newly diagnosed pediatric high grade glioma and diffuse intrinsic pontine glioma and recurrent medulloblastoma
$697,061Daniel Bryce Landi · Duke University · R01 · FY2021 · FD
An HB Vaccine Model For HIV Vaccine Trials in Drug Users
$697,045University Of Texas Hlth Sci Ctr Houston · R01 · FY2004 · DA
Immunological characterization of the P. vivax DBP
$697,044John Adams · University Of South Florida · R01 · FY2010 · AI
EIAV Envelope Variation and Vaccine Efficacy
$697,023Ronald C Montelaro · University Of Pittsburgh At Pittsburgh · R01 · FY2010 · AI
Durable Vaginal Protection from HIV via mRNA expression of BNABS
$697,003Philip J Santangelo · Emory University · R01 · FY2024 · AI
Mali International Center for Excellence in Research: Parasitic Infectious Diseases and their Vectors
$696,938Carole Long · National Institute Of Allergy And Infectious Diseases · ZIA · FY2014 · AI
Developing Immunotherapeutics for Methamphetamine Abuse
$696,926Thomas Richard Kosten · Baylor College Of Medicine · U01 · FY2009 · DA
CAREER: Rational Design of Immune Cell-Homing Biomaterials for Immune Regulation
$696,864Hua Wang · University Of Illinois At Urbana-Champaign · · FY2022 · MPS
Community-Centered Interventions for Improved Vaccine Uptake for COVID (CIVIC)
$696,776Erica E Marsh · University Of Michigan At Ann Arbor · R01 · FY2022 · MD
Mechanisms of Ebola virus-mediated inflammatory activation linked to pathogenesis
$696,742Michael A Barry · Mayo Clinic Rochester · R01 · FY2021 · AI
Project 2
$696,607Michael S. Diamond · Washington University · U19 · FY2025 · AI
Immunogenicity to B and T cell vaccines in non-human primates (NHPs)
$696,578Bali Pulendran · Stanford University · U19 · FY2024 · AI
Gut Microbial and Metabolic Mediators of Rotavirus Vaccine Response
$696,500Pia S Pannaraj · Children'S Hospital Of Los Angeles · R01 · FY2022 · HD
GLYCOSYLATION MUTANTS OF LEISHMANIA
$696,492Stephen M Beverley · Washington University · R01 · FY2018 · AI
M. tuberculosis exosome detection for pediatric TB diagnosis
$696,418Sylvia Lacourse · University Of Washington · R01 · FY2021 · AI
Host Genetic Epidemiology in HIV-1-Discordant African Couples and Other Cohorts
$696,335Richard A Kaslow · University Of Alabama At Birmingham · R01 · FY2009 · AI
Mechanisms of MRSA intestinal colonization
$696,333Bo Shopsin · New York University School Of Medicine · R01 · FY2024 · AI
Evaluating a Comprehensive Multimodal Outpatient Rehabilitation Program to Improve the Functioning of Persons Suffering from Post-acute Sequelae of SARS-CoV-2 infection (PASC): A Randomized Controlled
$696,313Timothy R Dillingham · University Of Pennsylvania · R01 · FY2023 · HD
Development of small near-infrared laser system capable of improving immune responses to vaccines (laser-based adjuvant)
$696,264David Bean · Veralase, Llc · R42 · FY2016 · AI
Household Transmission of Cryptosporidium
$696,243Poonum S. Korpe · Johns Hopkins University · R01 · FY2020 · AI
Community Engagement Core
$696,179Michele D Kipke · Children'S Hospital Of Los Angeles · P50 · FY2025 · MD
Role of neutralizing antibodies in HIV-1-infected and vaccinated mothers in MTCT
$696,137Amit Kumar · Duke University · R01 · FY2019 · AI
Protection of Hepatocyte Transplants by Engineered Veto
$696,116Uwe D. Staerz · Isogenis, Inc. · R44 · FY2011 · DK
Fox COBRE Phase II Admin Core
$696,115Joseph M Fox · University Of Delaware · P20 · FY2022 · GM
Mechanisms of Pain and Immune Processes
$696,064Michael J. Iadarola · National Institute Of Dental & Craniofacial Research · ZIA · FY2012 · DE